Annual Operating Expenses
$21.44 M
-$3.38 M-13.63%
December 31, 2023
Summary
- As of February 25, 2025, BCLI annual total operating expenses is $21.44 million, with the most recent change of -$3.38 million (-13.63%) on December 31, 2023.
- During the last 3 years, BCLI annual operating expenses has fallen by -$10.24 million (-32.33%).
- BCLI annual operating expenses is now -32.33% below its all-time high of $31.68 million, reached on December 31, 2020.
Performance
BCLI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.05 M
+$66.00 K+2.21%
September 30, 2024
Summary
- As of February 25, 2025, BCLI quarterly total operating expenses is $3.05 million, with the most recent change of +$66.00 thousand (+2.21%) on September 30, 2024.
- Over the past year, BCLI quarterly operating expenses has stayed the same.
- BCLI quarterly operating expenses is now -81.64% below its all-time high of $16.60 million, reached on December 31, 2004.
Performance
BCLI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BCLI Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | 0.0% |
| 3 y3 years | -32.3% | 0.0% |
| 5 y5 years | +52.5% | 0.0% |
BCLI Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.6% | at low | -59.9% | +23.2% |
| 5 y | 5-year | -32.3% | at low | -73.5% | +23.2% |
| alltime | all time | -32.3% | >+9999.0% | -81.6% | +1380.7% |
Brainstorm Cell Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.05 M(+2.2%) |
| Jun 2024 | - | $2.98 M(+20.5%) |
| Mar 2024 | - | $2.47 M(-48.5%) |
| Dec 2023 | $21.44 M(-13.6%) | $4.80 M(-20.4%) |
| Sep 2023 | - | $6.04 M(+10.8%) |
| Jun 2023 | - | $5.45 M(+5.8%) |
| Mar 2023 | - | $5.15 M(+4.8%) |
| Dec 2022 | $24.82 M(+1.2%) | $4.92 M(-28.2%) |
| Sep 2022 | - | $6.84 M(-9.9%) |
| Jun 2022 | - | $7.59 M(+38.6%) |
| Mar 2022 | - | $5.47 M(-11.9%) |
| Dec 2021 | $24.54 M(-22.6%) | $6.21 M(+17.7%) |
| Sep 2021 | - | $5.28 M(-13.8%) |
| Jun 2021 | - | $6.12 M(-11.7%) |
| Mar 2021 | - | $6.93 M(-39.7%) |
| Dec 2020 | $31.68 M(+37.8%) | $11.49 M(+156.2%) |
| Sep 2020 | - | $4.49 M(-39.4%) |
| Jun 2020 | - | $7.40 M(-10.9%) |
| Mar 2020 | - | $8.31 M(+8.4%) |
| Dec 2019 | $23.00 M(+63.6%) | $7.67 M(+38.1%) |
| Sep 2019 | - | $5.55 M(+14.3%) |
| Jun 2019 | - | $4.86 M(-1.4%) |
| Mar 2019 | - | $4.93 M(-9.4%) |
| Dec 2018 | $14.06 M(+181.3%) | $5.44 M(+68.2%) |
| Sep 2018 | - | $3.23 M(+4.7%) |
| Jun 2018 | - | $3.09 M(+33.8%) |
| Mar 2018 | - | $2.31 M(-1069.3%) |
| Dec 2017 | $5.00 M(-1.7%) | -$238.00 K(-109.9%) |
| Sep 2017 | - | $2.39 M(+122.5%) |
| Jun 2017 | - | $1.07 M(-39.3%) |
| Mar 2017 | - | $1.77 M(+172.3%) |
| Dec 2016 | $5.08 M(-40.5%) | $650.00 K(-60.3%) |
| Sep 2016 | - | $1.64 M(+66.6%) |
| Jun 2016 | - | $983.00 K(-45.8%) |
| Mar 2016 | - | $1.81 M(+29.7%) |
| Dec 2015 | $8.54 M(+15.0%) | $1.40 M(-45.7%) |
| Sep 2015 | - | $2.57 M(+8.8%) |
| Jun 2015 | - | $2.36 M(+7.2%) |
| Mar 2015 | - | $2.21 M(-17.3%) |
| Dec 2014 | $7.42 M(+47.2%) | $2.67 M(+9.7%) |
| Sep 2014 | - | $2.43 M(+87.8%) |
| Jun 2014 | - | $1.29 M(+25.5%) |
| Mar 2014 | - | $1.03 M(-26.4%) |
| Dec 2013 | $5.04 M | $1.40 M(+30.2%) |
| Sep 2013 | - | $1.08 M(-27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.49 M(+37.4%) |
| Mar 2013 | - | $1.08 M(+70.2%) |
| Dec 2012 | $3.52 M(-9.7%) | $635.00 K(-45.8%) |
| Sep 2012 | - | $1.17 M(+40.7%) |
| Jun 2012 | - | $833.00 K(-5.2%) |
| Mar 2012 | - | $879.00 K(-37.3%) |
| Dec 2011 | $3.89 M(+50.4%) | $1.40 M(+89.6%) |
| Sep 2011 | - | $740.00 K(-47.7%) |
| Jun 2011 | - | $1.42 M(+168.0%) |
| Mar 2011 | - | $528.00 K(-27.6%) |
| Dec 2010 | $2.59 M(+47.9%) | $729.00 K(+14.8%) |
| Sep 2010 | - | $635.00 K(+3.1%) |
| Jun 2010 | - | $616.00 K(+1.1%) |
| Mar 2010 | - | $609.00 K(+554.8%) |
| Dec 2009 | $1.75 M(-46.5%) | $93.00 K(-84.3%) |
| Sep 2009 | - | $593.00 K(+13.2%) |
| Jun 2009 | - | $524.00 K(-3.0%) |
| Mar 2009 | - | $540.00 K(-20.0%) |
| Dec 2008 | $3.27 M(-33.5%) | $675.00 K(-3.2%) |
| Sep 2008 | - | $697.00 K(-8.5%) |
| Jun 2008 | - | $762.00 K(-32.8%) |
| Mar 2008 | - | $1.13 M(+91.2%) |
| Dec 2007 | $4.92 M(+70.5%) | $593.00 K(-59.3%) |
| Sep 2007 | - | $1.46 M(+68.8%) |
| Jun 2007 | - | $863.00 K(-35.5%) |
| Mar 2007 | - | $1.34 M(+50.4%) |
| Dec 2006 | $2.88 M(-12.7%) | - |
| Sep 2006 | - | $890.00 K(+6.9%) |
| Jun 2006 | - | $832.40 K(+33.3%) |
| Mar 2006 | - | $624.30 K(-31.8%) |
| Mar 2006 | $3.30 M(-82.5%) | - |
| Dec 2005 | - | $915.00 K(-11.1%) |
| Sep 2005 | - | $1.03 M(+40.4%) |
| Jun 2005 | - | $732.80 K(+13.2%) |
| Mar 2005 | $18.83 M(>+9900.0%) | $647.60 K(-96.1%) |
| Dec 2004 | - | $16.60 M(+954.4%) |
| Sep 2004 | - | $1.57 M(>+9900.0%) |
| Dec 2003 | - | $14.60 K(+32.7%) |
| Sep 2003 | - | $11.00 K(-7.6%) |
| Jun 2003 | - | $11.90 K(+357.7%) |
| Mar 2003 | $58.00 K(+51.4%) | $2600.00(-90.8%) |
| Dec 2002 | - | $28.30 K(+78.0%) |
| Sep 2002 | - | $15.90 K(+42.0%) |
| Jun 2002 | - | $11.20 K |
| Mar 2002 | $38.30 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual operating expenses year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly operating expenses year-on-year change?
What is Brainstorm Cell Therapeutics annual total operating expenses?
The current annual operating expenses of BCLI is $21.44 M
What is the all time high annual operating expenses for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual total operating expenses is $31.68 M
What is Brainstorm Cell Therapeutics annual operating expenses year-on-year change?
Over the past year, BCLI annual total operating expenses has changed by -$3.38 M (-13.63%)
What is Brainstorm Cell Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BCLI is $3.05 M
What is the all time high quarterly operating expenses for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly total operating expenses is $16.60 M
What is Brainstorm Cell Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BCLI quarterly total operating expenses has changed by $0.00 (0.00%)